SCHEMBL123476

SCHEMBL123476

CCCOC(=O)CCN1CCN(C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 3/20 0.48
THRA P10827 1/20 0.48
TP53 P04637 2/20 0.47
PAOX Q6QHF9 1/20 0.43
ALDH1A1 P00352 7/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPT P10636 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
TSHR P16473 1/20 0.40
DGKA P23743 1/20 0.40
MAPK1 P28482 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM5 P08912 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
ADRA2C P18825 1/20 0.38
DRD4 P21917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL419258 0.94 ALDH1A1 (0.46) THRBTHRATP53ALDH1A1L3MBTL1
SCHEMBL674334 0.94 ALDH1A1 (0.46) THRBTHRATP53ALDH1A1L3MBTL1
SCHEMBL822424 0.91 THRB (0.47) THRBTHRATP53PAOXALDH1A1
SCHEMBL13601497 0.90 THRB (0.56) THRBTHRATP53PAOXALDH1A1
SCHEMBL12879889 0.90 PAOX (0.49) THRBTHRAPAOXALDH1A1L3MBTL1
SCHEMBL18068757 0.88 THRB (0.51) THRBTHRATP53PAOXALDH1A1
SCHEMBL421366 0.87 ALDH1A1 (0.43) THRBTHRATP53ALDH1A1L3MBTL1
SCHEMBL13601500 0.87 THRB (0.60) THRBTHRATP53PAOXL3MBTL1
SCHEMBL499698 0.87 THRB (0.60) THRBTHRATP53PAOXL3MBTL1
SCHEMBL13485578 0.86 TP53 (0.47) THRBTHRATP53PAOXALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use OPTIMER PHOTONICS, INC. (US) 2012-03-08 US disclosed
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE SEPRACOR INC. (US) 2010-05-13 US disclosed
US-7625886-B2 Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-12-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120059163-A1 Non-linear opticaly active molecules, their synthesis, and use INCENP, CYBA, ADCY5 THRB 4746/4885THRA 4764/4885TP53 4708/4885
US-20100120740-A1 PRODRUGS OF FUSED HETEROCYCLIC INHIBITORS OF D-AMINO ACID OXIDASE DDO, DAO, AOC1 THRB 1558/4885THRA 1876/4885TP53 2774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.